Clinical study about application site reaction in the oxybutynin transdermal patch - Clinical study about application site reaction in the oxybutynin transdermal patch

Suzuka University of Medical Science0 个研究点目标入组 15 人开始时间: 2017年12月17日最近更新: 2023年10月17日

研究概览

简要总结

Application of heparinoid cream increased skin hydration without altering transepidermal water loss. No obvious application site reaction was observed during treatment with oxybutynin transdermal patch. Overactive bladder symptom score significantly decreased during treatment (70% of patients showed a decrease of > 3 points after 12 weeks).

研究设计

研究类型: Observational

入排标准

年龄范围: 65years-old 至 100years-old（—）
性别: All

入选标准

未提供

排除标准

•1)uroschesis 2)closed-angle glaucoma 3)pylorus, duodenum or intestinal tract blockage 4)paralytic ileus 5)gastric or intestinal atony 6)myasthenia gravis 7)history of oxybutynin hydrochloride hypersensitivity were excluded

研究者

发起方

Suzuka University of Medical Science

相似试验

已完成

不适用

BILATERAL COMPARISON OF LIQUID PARAFFIN AND CREAM BASE ON TRANSEPIDERMAL WATER LOSS AMONG PSORIASIS PATIENTS: A RANDOMIZED TRIAPsoriasis is a common chronic inflammatory disease. Psoriasis patients experience pain&#44discomfort and skin dryness. Skin moisturizing is a major component of treatment for these patients.RANDOMIZED CONTROL TRIAL / PSORIASIS / TRANSEPIDERMAL WATER LOSS / SKIN HYDRATION

TCTR20160404002Institute of Dermatology100

招募中

3 期

The effect of heparin gel in improving hand and foot syndrome in patients treated with capecitabine

IRCT20230215057423N1Shahre-kord University of Medical Sciences40

招募中

不适用

Clinical study of heparinoid for sweating response in healthy volunteer.healthy control

JPRN-UMIN000026469Department of dermatology, Kawasaki Medical School, 577 Matsushima Kurashiki city, Okayama Japan30

已完成

1 期

Prevention of local skin reaction by heparinoid due to rotigotine transdermal patch: a pilot randomized clinical trial.Parkinson's diseases disease

JPRN-UMIN000033409Wakayama Medical University20

尚未招募

3 期

To test whether application of topical heparin solution around the IV cannula site daily would reduce the occurrence of superficial inflammation of veins when compared to a placebo

CTRI/2024/06/069653All India Institute of Medical Sciences, Mangalagiri